Intriguingly, when the tumors were stratified according to PAM50 subtypes [35], there was a further enrichment of FAK amplifications (38.7%) in patients with basal-like breast cancer (Fisher’s exact test, p < 0.0001) (Fig. 1b). This evidence concerns the gene PTK2 and breast carcinoma.